PT Medikaloka Hermina Tbk (HEAL) has completed an additional capital without pre-emptive rights issue (PMTHMETD) or a private placement earlier this year.

HEAL offers 5 million new shares with a nominal value of Rp100 per share and a private placement price of Rp 4,000 per share.

Through this private placement, HEAL proceeds up to Rp20 billion. Luminous Investments is the strategic investor that absorbs the offer.

Director of Medikaloka Hermina, Aristo Setiawidjaja, said that Hermina plans to use the private placement proceeds for business development, including medical devices' modernization.

"This is in line with our strategy to develop specialty beyond mothers and children," said Aristo, on Wednesday (27/1).

Currently, according to Arsito, HEAL is developing radiotherapy for cancer patients.

"HEAL is indeed closely related to the image of a mother and child hospital. However, since the last decade, HEAL has also served many patients outside that market segment, such as heart, eye, and bone patients, "he explained.

This year, HEAL plans to add four new hospitals in Cibitung, Cilegon, and Aceh and acquire one hospital.

Hermina is preparing a capital expenditure (Capex) allocation of between Rp800 billion to Rp900 billion with this expansion plan. In addition to adding hospitals, Hermina will use Capex to add more beds in existing hospitals.